Expand GCTK Menu
GCTK MENU

GCTK Latest Press Releases

-- September 2, 2026 --

Lokahi Therapeutics Expands ai Futures Lab Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business Business Wire 9:15 AM

-- August 27, 2026 --

Glucotrack, Inc. Announces Reverse Stock Split Business Wire 8:00 AM

-- August 25, 2026 --

Lokahi Therapeutics Initiates Clinical Trial Manufacturing for LT-100 Business Wire 8:00 AM

-- August 21, 2026 --

Lokahi Therapeutics Expands ai Futures Lab Asset Origination Network Through Continued Collaboration with the University of Georgia Business Wire 8:00 AM

-- August 17, 2026 --

Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation Business Wire 8:00 AM

-- August 6, 2026 --

E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack Globe Newswire 8:15 AM

-- August 5, 2026 --

Glucotrack Announces $5.5 Million Financing Business Wire 8:30 AM

-- August 3, 2026 --

CORRECTING and REPLACING Lokahi Therapeutics ai Futures Lab Changes How Biopharma Builds a Pipeline Business Wire 8:49 AM

-- July 31, 2026 --

Lokahi Therapeutics ai Futures Lab Changes How Biopharma Builds a Pipeline Business Wire 8:00 AM

-- July 29, 2026 --

Lokahi Therapeutics Advances LT-100 Development Strategy Toward Single-Injection Administration Business Wire 5:30 PM

-- July 17, 2026 --

E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lokahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing Globe Newswire 1:20 PM
Glucotrack, Inc. and Lokahi Therapeutics Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives Globe Newswire 8:05 AM

-- July 16, 2026 --

UPDATE - Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform Globe Newswire 4:57 PM

-- July 14, 2026 --

Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform Globe Newswire 5:40 PM

-- July 8, 2026 --

Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform Globe Newswire 8:00 AM

-- May 26, 2026 --

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions Globe Newswire 8:00 AM

-- May 14, 2026 --

Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights Globe Newswire 5:27 PM

-- May 7, 2026 --

Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology Globe Newswire 1:00 PM

-- April 30, 2026 --

Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology Globe Newswire 9:00 AM

-- April 21, 2026 --

Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes